News

Analyses strengthen FLAME’s findings


 

At THE ERS CONGRESS 2016

References

Overall, the results from the FLAME post hoc analyses have demonstrated “remarkable consistency,” Dr. Wedzicha reported. Taken together, she said the data “imply that LABA/LAMA is the first choice of treatment for COPD patients at risk of exacerbation.”

Pages

Next Article:

Decision rule identifies unprovoked VTE patients who can halt anticoagulation